Cas:24845-40-7 2-(4-methoxyphenyl)-1-phenylethanone manufacturer & supplier

Chemical Name:2-(4-methoxyphenyl)-1-phenylethanone

CAS.NO:24845-40-7

Synonyms:p-Methoxybenzyl phenyl ketone;4′-Methoxydeoxybenzoin;2-(p-Methoxyphenyl)acetophenone;4-Methoxy-2-Phenylacetophenone;Ethanone, 2-(4-methoxyphenyl)-1-phenyl-;2-(4-Methoxyphenyl)-1-phenylethanone

Molecular Formula:C₁₅H₁₄O₂

Molecular Weight:226.270

HS Code:2914509090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:362.0±17.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.570

PSA:26.30000

Exact Mass:226.099380

LogP:3.09

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like p-Methoxybenzyl phenyl ketone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-Methoxyphenyl)-1-phenylethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-Methoxyphenyl)-1-phenylethanone Use and application,4-Methoxy-2-Phenylacetophenone technical grade,usp/ep/jp grade.

Related News: The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). 2-(4-methoxyphenyl)-1-phenylethanone manufacturer ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 2-(4-methoxyphenyl)-1-phenylethanone supplier Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 2-(4-methoxyphenyl)-1-phenylethanone vendor Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. 2-(4-methoxyphenyl)-1-phenylethanone factory Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost.